Publication | Closed Access

Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A

InflammationThrombosisHematologyImmunologyPathologyRecombinant Factor ViiiFibrinolysisHemostasisCoagulopathyBleeding DisorderMedicineClot ResistanceTranexamic Acid